The article highlights the significant disruption to health initiatives due to the Trump administration's temporary halt on foreign aid, impacting countries like Uganda and Zambia. Programs such as the National Malaria Control Program have been forced to suspend life-saving actions, including the distribution of insecticide and medical supplies. Numerous clinical trials across South Asia, Africa, and Latin America have also ceased, leaving thousands of participants without crucial treatments. Interviews reveal a deep sense of fear and sorrow among health workers, as they worry about the loss of decades of their work and the implications for future funding.
Lifesaving health initiatives and medical research projects have shut down around the world in response to the Trump administration's 90-day pause on foreign aid and stop-work orders.
Medical supplies, including drugs to stop hemorrhages in pregnant women and rehydration salts that treat life-threatening diarrhea in toddlers, cannot reach villages in Zambia.
Dozens of clinical trials in South Asia, Africa and Latin America have been suspended; thousands of participants affected without access to necessary treatment.
Many researchers described the upheaval in health systems in developing nations, fearing they could jeopardize future funding if they spoke out.
Collection
[
|
...
]